Allergan

Page 3 of 6

White tablets
Health

Teva Says Its Deal to Buy Allergan’s Generics Business Will Close ‘Any Time’

By
July 13, 2016
Carl Icahn Recently Bought a ‘Large Position’ in Allergan
Finance

Carl Icahn Recently Bought a ‘Large Position’ in Allergan

By
May 31, 2016
CNBC Events
Finance

Allergan Is Buying Back Up to $10 Billion in Stock

By Reuters and Coins2Day Editors
May 10, 2016
Stocks Close Sharply Lower As Oil Prices Continue Decline
Finance

These Biopharma Companies Are the World’s Top Shareholder Value Creators

By
May 3, 2016
The CEO of Valeant Pharmaceuticals has suggested that Allergan is fat, overstaffed and ripe for big
Health

Allergan Struck a $3.3 Billion Alzheimer’s Drug Deal Right After Its Pfizer Merger Collapsed

By
April 7, 2016
Pfizer In Merger Talks With Allergan PLC
Health

Pfizer and Allergan Scrap $160 Billion Deal

By
April 6, 2016
Pfizer In Merger Talks With Allergan PLC
Finance

Pfizer, Allergan to Mutually Terminate Merger

By
April 6, 2016
Pfizer Inc. Headquarters As They Agree To Combine With Allergan Plc In $160 Billion Deal
Finance

Wall Street Is Betting the Pfizer-Allergan Deal Won’t Happen

By
April 5, 2016
Pfizer Inc. Headquarters As They Agree To Combine With Allergan Plc In $160 Billion Deal
Leadership

Here’s Why Allergan Shares Are Tanking

By
April 5, 2016
Why Teva’s $40 Billion Deal for Allergan’s Generic Drugs Is Being Delayed
Health

Why Teva’s $40 Billion Deal for Allergan’s Generic Drugs Is Being Delayed

By
March 16, 2016
Pfizer Inc. Headquarters As They Agree To Combine With Allergan Plc In $160 Billion Deal
Finance

Here’s How Much More Pfizer Could Save in Taxes With Allergan Deal

By
February 26, 2016
U.S. Multinationals in Puerto Rico
Health

Eli Lilly Just Lost the Latest Round in its Patent Battle

By
February 12, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Biotech Stocks Crashed and Nobody Knows Why

By
January 29, 2016
Inside Teva Pharmaceuticals Headquarters
Health

Celgene Settles U.S. Patent Litigation for Revlimid

By Reuters and Aaron Task
December 23, 2015
Pfizer Inc. Headquarters As They Agree To Combine With Allergan Plc In $160 Billion Deal
Finance

2015 Is Now the Biggest Year Ever for M&A

By
December 4, 2015

Most Popular